Cargando…

Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma

Despite advances in surgery and chemotherapy, the prognosis of patients with hepatocellular carcinoma (HCC) remains poor. In the present study, the role of S100A1 in the progression of HCC was investigated. Immunohistochemical staining was used to measure the expression of S100A1 in HCC tissues. S10...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Qingping, Wang, Jiale, Cao, Zeyu, Tang, Yongchang, Feng, Chao, Huang, Feizhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017223/ https://www.ncbi.nlm.nih.gov/pubmed/29901195 http://dx.doi.org/10.3892/ijo.2018.4431

Ejemplares similares

TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma
por: Dong, Qianze, et al.
Publicado: (2017)

LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling
por: Cheng, Yang, et al.
Publicado: (2018)

An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2
por: Park, Gun-Soo, et al.
Publicado: (2016)

Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner
por: García-Gutiérrez, Lucía, et al.
Publicado: (2022)

LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control
por: Gan, Wenjian, et al.
Publicado: (2020)

PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
por: Ji, Jianxiong, et al.
Publicado: (2019)

Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells
por: Darbankhales, Soroush, et al.
Publicado: (2020)

Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase–mediated inhibitory phosphorylation of the transcriptional coactivator YAP
por: Thines, Louise, et al.
Publicado: (2022)

POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
por: Rahmat, Muhammad Bakhait, et al.
Publicado: (2019)

RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
por: Pan, Yi, et al.
Publicado: (2018)

Correction: POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
por: Rahmat, Muhammad Bakhait, et al.
Publicado: (2019)

S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development
por: Hu, Yifang, et al.
Publicado: (2023)

Small molecule LATS kinase inhibitors block the Hippo signaling pathway and promote cell growth under 3D culture conditions
por: Aihara, Ayako, et al.
Publicado: (2022)

Lats2 Modulates Adipocyte Proliferation and Differentiation via Hippo Signaling
por: An, Yang, et al.
Publicado: (2013)

A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
por: Azad, T., et al.
Publicado: (2018)

LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma
por: Guo, Chengyong, et al.
Publicado: (2019)

O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity
por: Kim, Eunah, et al.
Publicado: (2020)

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
por: Meng, Zhipeng, et al.
Publicado: (2015)

Structural basis for Mob1-dependent activation of the core Mst–Lats kinase cascade in Hippo signaling
por: Ni, Lisheng, et al.
Publicado: (2015)

Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation
por: Najafi, Maryam, et al.
Publicado: (2016)

Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1
por: Le, Truc Phan Hoang, et al.
Publicado: (2023)

WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression
por: Han, Qiang, et al.
Publicado: (2021)

Lats1/2-Mediated Alteration of Hippo Signaling Pathway Regulates the Fate of Bone Marrow-Derived Mesenchymal Stem Cells
por: Li, Lang, et al.
Publicado: (2018)

Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway
por: Wang, Chien-Hao, et al.
Publicado: (2023)

Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling
por: Hergovich, Alexander
Publicado: (2013)

Molecular regulation of trophoblast stem cell self-renewal and giant cell differentiation by the Hippo components YAP and LATS1
por: Basak, Trishita, et al.
Publicado: (2022)

CADM1 associates with Hippo pathway core kinases; membranous co–expression of CADM1 and LATS2 in lung tumors predicts good prognosis
por: Ito, Takeshi, et al.
Publicado: (2019)

RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2
por: Roßwag, Sven, et al.
Publicado: (2021)

Zyxin-Siah2–Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways
por: Ma, Biao, et al.
Publicado: (2016)

DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins
por: Nguyen, Hung Thanh, et al.
Publicado: (2017)

miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2
por: Mohamed, Zeinab, et al.
Publicado: (2018)

Novel insights into the regulation of LATS2 kinase in prehierarchical follicle development via the Hippo pathway in hen ovary
por: Sun, Xue, et al.
Publicado: (2021)

Protocols for measuring phosphorylation, subcellular localization, and kinase activity of Hippo pathway components YAP and LATS in cultured cells
por: Luo, Min, et al.
Publicado: (2022)

MicroRNA-93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarction
por: Ma, Chengjie, et al.
Publicado: (2020)

ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma
por: Chen, Qian, et al.
Publicado: (2021)

The Hippo kinase LATS2 impairs pancreatic β-cell survival in diabetes through the mTORC1-autophagy axis
por: Yuan, Ting, et al.
Publicado: (2021)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma
por: Suzuki, Koya, et al.
Publicado: (2022)

Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma
por: Gao, Yanping, et al.
Publicado: (2017)

Skeletal muscle phenotyping of Hippo gene-mutated mice reveals that Lats1 deletion increases the percentage of type I muscle fibers
por: Nezhad, Fakhreddin Yaghoob, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3525t6hf7ogi70ep3k06lo3ci6